Target intelligence / Profile preview

Alcohol dehydrogenase class-3 (glutathione-dependent formaldehyde dehydrogenase) (ADH5)

Target
ADH5
Molecular classification
Enzyme, Alcohol dehydrogenase family, Oxidoreductase (EC: 1.1.1.1, 1.1.1.284)
01

Overview

Alcohol dehydrogenase class-3 (ADH5) is a human enzyme encoded by the ADH5 gene, and is a member of the alcohol dehydrogenase family. It operates as a homodimer and is best known for its role as a glutathione-dependent formaldehyde dehydrogenase, catalyzing the oxidation of S-hydroxymethyl-glutathione adducts, thus protecting against formaldehyde toxicity—a carcinogenic and cytotoxic metabolite. ADH5 further acts as S-nitrosoglutathione reductase (GSNOR), regulating nitric oxide signaling and protein S-nitrosylation. These functions are integral to cellular homeostasis, impacting detoxification, DNA repair, airway reactivity, and cardiovascular and immune responses. Deficiency or altered activity of ADH5 is linked to increased risk for cancer, inflammatory conditions (including asthma), Fanconi anemia, and disorders involving redox imbalance. While not directly a drug target in mainstream clinical therapy, ADH5 is actively researched for its biomarker and therapeutic potential, and the instability of its recombinant protein has posed technical challenges.

Other names
Alcohol dehydrogenase 5Alcohol dehydrogenase class chi chainADH-3ADHXFDHFALDHGSH-FDHS-(hydroxymethyl)glutathione dehydrogenaseS-nitrosoglutathione reductaseGlutathione-dependent formaldehyde dehydrogenaseFormaldehyde dehydrogenaseGSNORHEL-S-60p
02

Mechanism of action

GSNOR antagonists/inhibitors (increase S-nitrosylation by inhibiting nitrosoglutathione reduction, modulating redox and NO signaling) Formaldehyde scavengers (reduce substrate load, modulating ADH5 activity indirectly)

03

Biological functions

Formaldehyde detoxification (oxidizes S-hydroxymethyl-glutathione, facilitating clearance of endogenous formaldehyde)Regulation of S-nitrosylation (NADH-dependent reduction of S-nitrosoglutathione, controlling nitrosothiol signaling)Lipid metabolism (oxidizes long-chain omega-hydroxy fatty acids)Redox homeostasisMetabolism of a variety of alcohols and aldehydes
04

Disease associations

Cancer (formaldehyde-induced DNA damage is carcinogenic; ADH5 plays a protective role)Cardiovascular disease (implicated via control of nitric oxide signaling)Asthma/inflammatory disease (regulation of airway smooth muscle tone via NO signaling)Fanconi anemia and hematopoietic failure (involved in DNA crosslink repair due to formaldehyde detoxification)Other inflammatory conditions
05

Safety considerations

Off-target effects due to ADH family overlapPossible disruptions of NO signaling: risk of altered vascular tone, immune modulation, and airway reactivity if ADH5 is inhibitedAccumulation of toxic formaldehydePossible destabilization or misfolding issues: recombinant protein reported to be unstable in vitro, posing challenges for drug development
06

Interacting drugs

There are no widely approved drugs specifically targeting ADH5 clinically, but several small-molecule inhibitors/modulators exist for research, such as compounds targeting its GSNOR activity (e.g., N6022, C3)

1 more in the full profile.

07

Biomarkers

ADH5 expression/activityS-nitrosoglutathione levelsFormaldehyde-DNA adduct quantification in clinical models or research

Beyond the preview

Go deeper on Alcohol dehydrogenase class-3 (glutathione-dependent formaldehyde dehydrogenase) (ADH5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alcohol dehydrogenase class-3 (glutathione-dependent formaldehyde dehydrogenase) (ADH5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call